baber/WOPTO huggingface dataset:
Patent EP-1288644-A2 (EP)
Inventor: HUMERICKHOUSE CHARLES EDWARD
IPC: G05B23/02
Filed: 2002-08-28
Abstract: A method and system (100) for evaluating whether faults detected during the
testing of a gas turbine engine are related to the performance problems of the engine
or to some other abnormality unrelated to engine performance. One performance
parameter of the engine is evaluated (101) under one performance condition to
generate a first set of current engine data that is then compared (102) to a first set of
prior engine data to determine if there is an abnormality. If one is detected, this
performance parameter is then evaluated (104) under at least two different
performance conditions to generate a second set of current engine data that is
compared (105) to a second set of prior engine data to determine if there is an
abnormality. If one is detected, the abnormality is evaluated (106,107) to see if the
fault is unrelated to the performance of the engine. If one is not detected, this
performance parameter is evaluated (109) relative to at least one other performance
parameter to generate a third set of current engine data that is compared (110) to a
third set of prior engine data to determine if there is an abnormality. If one is detected
after this comparison of the third set of current to prior engine data, the abnormality is
then evaluated (110) to see if it is unrelated (108) to engine performance. If one is not
detected, the abnormality is then evaluated to determine (111) if the fault is related to
engine performance.
Patent EP-1399163-A2 (EP)
Inventor: BOYKIN DAVID
IPC: A61K31/341
Filed: 2002-01-11
Abstract: The present invention relates to novel compounds and methods that are useful in treating members of the Flaviviridae family of viruses. Compounds of the present invention will have a structure according to Formulas (I)-(VI) as recited throughout the application.
Patent EP-1296590-A2 (EP)
Inventor: MOERMAN PIET
IPC: G06Q50/22
Filed: 2002-02-08
Abstract: L'invention concerne un système de gestion pour le traitement personnalisé de pathologie, qui comprend un dispositif d'entrée, une unité consultative et un dispositif de sortie. Le dispositif d'entrée permet de transmettre à l'unité consultative des données relatives à l'état antérieur, courant et/ou futur du patient, en liaison avec la pathologie considérée. L'unité consultative permet de recevoir et d'enregistrer ces données, à partir du dispositif d'entrée, et de traiter les données en question pour établir une recommandation thérapeutique. Enfin, le dispositif de sortie permet de recevoir la recommandation thérapeutique depuis l'unité consultative et de transmettre cette recommandation au patient.
Patent EP-1365770-A2 (EP)
Inventor: CHAN TAI WAH
IPC: A61K9/22
Filed: 2002-02-07
Abstract: L'invention concerne des dispositifs et des méthodes d'administration d'une préparation à un individu en vue de stabiliser ou d'augmenter sa masse osseuse par augmentation du dépôt osseux et/ou par réduction de la résorption osseuse. Selon la présente invention, une préparation médicamenteuse comprenant un bisphosphonate est administrée de manière parentérale dans une forme posologique à libération prolongée, notamment sous la forme d'une matrice injectée, ou stockée dans un dispositif d'administration de médicament. Dans un mode de réalisation spécifique, la forme posologique peut être implantée ou injectée dans un site corporel (site d'implantation). Par ailleurs, un conduit tel qu'un cathéter peut être utilisé pour véhiculer la préparation issue de la forme posologique en vue d'une libération au niveau d'un site corporel distal par rapport au site d'implantation.
Patent EP-1373387-A2 (EP)
Inventor: HE ZHIQIANG ALEX
IPC: C09D7/45
Filed: 2002-02-22
Abstract: L'invention concerne de nouveaux agents acides fonctionnels dispersants de pigments. D'une manière plus spécifique, l'invention concerne de nouveaux polymères contenant des groupes fonctionnels acides destinés à servir de dispersants de pigments. Ces nouveaux polymères contiennent des amides polymères avec des groupes fonctionnels carboxyle qui présentent la structure (I) dans laquelle PE représente un polyester, PA représente une polyamine et A représente un anhydride. Les dispersants de pigments selon l'invention conviennent particulièrement à la dispersion de pigments organiques et de pigments à base de noir de carbone fortement coloré. Les avantages des nouveaux dispersants de pigments par rapport aux dispersants polymères fonctionnels amine sont nombreux. Ils n'ont pas tendance à se décolorer lorsqu'ils sont exposés à la lumière UV. Ils n'inhibent pas les réactions catalysées par un acide, telles que la réticulation de la mélamine, ne réagissent pas avec isocyanate et ne catalysent pas la réaction isocyanate/H2O. Ils sont non toxiques ou beaucoup moins toxiques pour les organismes aquatiques. Par conséquent, ces dispersants peuvent être utilisés dans des processus catalysés par un acide et isocyanate sans les effets indésirables des dispersants fonctionnels amine de la technique antérieure. Enfin, ces dispersants sont plus sûrs du point de vue écologique.
Patent EP-1405178-A2 (EP)
Inventor: NICOLLE PASCAL
IPC: G06F9/44
Filed: 2002-04-15
Abstract: The invention relates to a method of visualizing or graphically printing an automatism application programmed on a programming station (51) with the aid of graphic automatism languages (LD, SFC, FBD) on a computer terminal (54). Said method comprises a stage in which a source program (50) associated with an application program formulated in one of the graphic automatism languages is stored on the terminal (54), said source program being translated into a single, hierarchical object oriented language (XML);  a stage in which at least one style sheet (52) associated with a graphic language is stored on the computer (54) in order to generate a graphic vector file (53) containing drawing instructions enabling the automatism application to be displayed graphically on the terminal (54).
Patent EP-1382059-A2 (EP)
Inventor: DURCAN MARK D
IPC: H01L29/423
Filed: 2002-04-26
Abstract: A method of forming memory devices, such as DRAM access transistors, having recessed gate structures is disclosed. Field oxide area (21) for isolation are first formed over a semiconductor substrate subsequent to which transistor grooves (22) are patterned and etched in a silicon nitride layer (18). The field oxide areas adjacent to the transistor grooves are then recessed, so that subsequently deposited polysilicon for gate structure formation can be polished relative to the adjacent and elevated silicon nitride.
Patent EP-1405227-A2 (EP)
Inventor: BUCHANAN BRENT
IPC: G06F17/50
Filed: 2002-06-20
Abstract: Apparatus, method and program product for evaluating design code of an integrated circuit. A program assigns an identifier to a cell based upon a cell characteristic. The program catalogs the identifier in a database configured to store and recall the identifier and characteristic along with additional properties that pertain to the cell. The program may associate the identifier or characteristic with a cell embedded in the design code.
Patent EP-1383557-A2 (EP)
Title: Conformable balloonless catheter
Inventor: FLINCHBAUGH DAVID E
IPC: A61F5/44
Filed: 2002-04-01
Abstract: Indwelling catheter having an upper distal end having a portion that can expand within a bladder type spaces without having to be inflated as dislcosed. Magnetic valves (436) can be included inside the tube (420) of the catheter that can cycle between open and closed positions when activated by normal bladder pressure when urination is desired. The catheter tube can naturally conform to an opening and closing urethra during natural bladder drainage. Sampling ports (410) can be located on both inside catheter tube valves and on an externally attached magnetic valve.
Patent EP-1461418-A2 (EP)
Inventor: MYERS KENT R
IPC: C12N1/21
Filed: 2002-03-28
Abstract: Herein is disclosed a method for producing lipopolysaccharide (LPS), comprising: (a) growing a culture of a deep rough mutant bacterial strain in a medium; (b) maintaining the culture in stationary phase for at least about 5 hr; (c) harvesting cells from the culture; and (d) extracting LPS from the cells. The method allows for the production of an LPS which can be used to produce a 3-O-deacylated monophosphoryl lipid A (3D-MLA) having at least about 20 mol% of the hexaacyl congener group. Also herein is disclosed a method of extracting lipopolysaccharide (LPS) from a culture of deep rough mutant bacterial strain cells, comprising: (a) extracting the cells with a solution consisting essentially of at least about 75 wt% of an aliphatic alcohol having from 1 to 4 carbon atoms and the balance water, thereby producing cells with reduced phospholipid content; and (b) extracting the cells with reduced phospholipid content with a solution comprising chloroform and methanol, thereby yielding a solution of LPS in chloroform and methanol (CM). This method provides LPS solutions in CM that have reduced phospholipid content and are produced by relatively simple and inexpensive process steps.
Patent EP-1420785-A2 (EP)
Inventor: JAGTAP PRAKASH G
IPC: A61P1/02
Filed: 2002-08-30
Abstract: The invention provides novel classes of substituted indeno[1,2-c]isoquinoline compounds. Pharmaceutical compositions and methods of making and using the compounds are also described.
Patent EP-1388112-A2 (EP)
Inventor: GIANOTTEN JACCO JOSEPHUS HENDR
IPC: G06Q30/00
Filed: 2002-04-18
Abstract: Method and equipment for communicating a message, comprising the following steps: (a) selection of at least one plurality of respondents; (b) selection of at least one channel for communication with the at least one plurality of respondents; (c) adapting the message to the selected channel; and, for each respondent in the at least one plurality of respondents, (d) sending at least a portion of the message via the at least one channel. The invention can be used for carrying out research projects automatically. To this end the message comprises a research dialogue to obtain research responses and the invention comprises the following further steps: (e) receipt of results of the research dialogue; and (f) processing the results and storing the results in a predetermined format.
Patent EP-1385540-A2 (EP)
Inventor: THOMAS ANNE CHRISTINE
IPC: C12N5/02
Filed: 2002-05-03
Abstract: A composition and method for enhancing cell growth and increasing the density of cell cultures containing lentivirus-infected host cells comprises adding a suitable quantity of an antibiotic to the culture to destroy harmful bacteria.
Patent EP-1432815-A2 (EP)
Inventor: HAYSTEAD TIMOTHY A
IPC: G01N33/58
Filed: 2002-09-16
Abstract: The present invention relates, in general, to quinone reductase 2 (QR2) and aldehyde dehydrogenase (ALDH), and, in particular, to methods of screening compounds for their ability to modulate the activity of QR2 and/or ALDH and thereby to function as anti-malarial, anti-arthritic and/or anti-lupus agents. The invention further relates to the use of compounds that inhibit ALDH in the production of stem cells en masse.
Patent EP-1442427-A2 (EP)
Inventor: BRUIJNS JOHANNES
IPC: G06T7/00
Filed: 2002-10-14
Abstract: The present invention relates to a method of analyzing an object data set in which a tubular structure having a plurality of branches and bifurcations occurs, wherein the object data set assigns data values to positions in a multi-dimensional space, which data values relate to an object to be examined. The invention relates further to a corresponding apparatus and computer program.
Patent EP-1456364-A2 (EP)
Inventor: STRATTON MIKE
IPC: C12Q1/68
Filed: 2002-12-23
Abstract: The invention relates to mutations in B-Raf gene products. The mutations described are identified in human tumours of natural origin. These mutations are associated with cancerous phenotypes and can be used as a basis for the diagnosis of cancer, cancerous cells or a predisposition to cancer in human subjects, and the development of anti-cancer therapeutics.
Patent EP-1517724-A2 (EP)
Inventor: KALLURI RAGHURAM
IPC: C12N5/09
Filed: 2002-12-20
Abstract: Proteins with anti-angiogenic properties are disclosed, and fragments thereof, and methods of using those proteins and fragments to inhibit or promote angiogenesis.
Patent EP-1449405-A2 (EP)
Inventor: VAN PELT ENGELBERT
IPC: H04M1/60
Filed: 2002-10-14
Abstract: A modular headset comprises a first unit that has first and second operational modes. In the first operational mode, the unit has a stand-alone functionality and serves as a wireless earpiece of a mobile phone. To this end, the first unit has Bluetooth processing means onboard. In the second mode, the first unit is connected to a second unit, the latter being an earpiece for the other ear. The second unit has processing power onboard for generating stereo audio when coupled with an MP3 player. Resources of the second unit are shared with the first unit in the second operational mode.
Patent EP-1480607-A2 (EP)
Inventor: GOEPPEL ANJA
IPC: A61K8/37
Filed: 2002-11-02
Abstract: The invention relates to light-protective cosmetic or dermatological preparations that contain (a) at least one hydroxybenzophenone, and (b) at last one dialkyl naphthalate of the structural formula (I), wherein R1 and R2 are independently selected form the group of the branched and unbranched alkyl groups that have 6 to 24 carbon atoms. The invention further relates to the use of said formulations.
Patent EP-1458387-A2 (EP)
Inventor: FAHAM AMINA
IPC: A61K47/38
Filed: 2002-11-14
Abstract: The present invention concerns orodispersible tablets, which are able to disintegrate in the buccal cavity upon contact with saliva by formation of an easy-to-swallow suspension, in less than 60 seconds, preferably in less than 40 seconds, containing fexofenadine in the form of coated granules, and a mixture of excipients comprising at least one disintegrating agent, a soluble diluent agent, a lubricant and optionally a swelling agent, a permeabilising agent, sweeteners, flavoring agents and colors; the process for obtaining such orodispersible tablets and the coated granules incorporated therein and the use of said orodispersible tablets in the treatment of seasonal allergic rhinitis.
Patent EP-1323749-A2 (EP)
Inventor: SAGANE TOSHIHIRO
IPC: C08L23/16
Filed: 1995-12-20
Abstract: Disclosed is an ethylene-α-olefin-nonconjugated polyene
random copolymer having such properties that (i) the
copolymer contains units derived from ethylene (a) and units
derived from the α-olefin of 3 or more carbon atoms (b) in a
molar ratio of 40/60 to 64/36 [(a)/(b)], (ii) the iodine
value is 1 to 50, (iii) the intrinsic viscosity (η) is more
than 0.3 dl/g and less than 5.0 10 dl/g, (iv) the intensity
ratio D of Tαβ to Tαα in the  13 C-NMR spectrum, Tαβ/Tαα is
not more than 0.5, (v) the B value is 1.00 to 1.50 and (vi)
the glass transition temperature Tg is not higher than
-50°C. Also disclosed is a vulcanizable rubber composition
containing the random copolymer. A process of preparing this
copolymer by using a metallocene catalyst containing a
specified metallocene compound is also disclosed. The
ethylene-α-olefin-nonconjugated polyene random copolymer and
the rubber composition are excellent in mechanical strength,
weathering resistance, ozone resistance, processability, low
temperature flexibility and heat resistance.
Patent EP-1344686-A2 (EP)
Inventor: RATH JOACHIM
IPC: B60R1/07
Filed: 2003-02-27
Abstract: The device has at least one mirror section that can be moved and/or deformed by an adjuster and at least one device for detecting state data for the road and/or the vehicle. A control unit is provided that controls the adjuster depending on the state data to move and/or deform the mirror section.
Patent EP-1365459-A2 (EP)
Inventor: BRAUNGER EUGEN
IPC: H01M50/164
Filed: 2003-03-13
Abstract: Voltaic cell element comprises a cell lid having an outer surface coated with a nickel-free copper/tin (Cu/Sn) alloy.  An Independent claim is also included for an alternative voltaic cell element having a cell lid whose outer surface is coated with a nickel-free copper/tin/zinc (Cu/Sn/Zn) alloy. Preferably the alloy contains 20-90% copper, 50-60% copper and the remainder Sn, or 75-85% copper and the remainder Sn. The outer and inner sides of the cell lid and the inner and/or outer sides of the cell vessel are coated with the alloy. The coating is 0.05-10 microns thick.
Patent EP-1354682-A2 (EP)
Inventor: BAILEY DAVID WILLIAM
IPC: B60C17/04
Filed: 2003-04-10
Abstract: A collapsible mechanism for molding the bead of a tire includes a series of sectors (132,134) configured for
radial and diagonal movement to selectively apply a continuous, uniform surface (148,150) for molding and shaping
the bead. The sectors collapse into a retracted, release position to allow for placement of the tire within
and removal of the tire from the mold.
Patent EP-1369440-A2 (EP)
Inventor: MICHL KATHRIN DR
IPC: C08F220/02
Filed: 2003-05-16
Abstract: An ethylenically unsaturated monocarboxylic acid and/or dicarboxylic acid (monomer A) (in wt.%) (50-99.5), an ethylenically unsaturated compound chosen from specific esters (0.5-50) (monomer B), and an optional monomer (monomer C) (up to 20) are polymerized in aqueous medium in the presence of foam inhibitor(s), to prepare an aqueous copolymer solution.  An ethylenically unsaturated monocarboxylic acid and/or dicarboxylic acid (monomer A) (in wt.%) (50-99.5), ethylenically unsaturated compound (0.5-50) (monomer B), and an optional monomer (monomer C) (up to 20), are polymerized in an aqueous medium in the presence of at least one foam inhibitor, to prepare an aqueous copolymer solution. The monomer (B) is chosen from esters of ethylenically unsaturated monocarboxylic acids and monoesters and diesters of ethylenically unsaturated dicarboxylic acids with an amine containing at least one hydroxyl group.
Patent EP-1367398-A2 (EP)
Inventor: YOSHIKAWA KEIKO
IPC: G01N35/04
Filed: 2003-05-28
Abstract: An automatic analyzing apparatus has an analysis
section including an immunity analysis unit and a
biochemical componential analysis unit. A sample rack which
has undergone the immunity componential analysis is
horizontally fed by a rack feeding mechanism from a position
confronting the inlet of a rack stationing section to a
position near the outlet of the rack stationing section, so
that the sample rack is directly moved to a return line,
while skipping over the rack stationing section, so as to be
efficiently returned to the analysis section and subjected
to a subsequent biochemical analysis. A sample rack that
needs reexamination by an identical analysis unit is also
returned in the same efficient way.
Patent EP-1369860-A2 (EP)
Inventor: SHINGAI HIROSHI
IPC: G11B7/243
Filed: 2003-05-28
Abstract: There is provided an optical recording medium
formed based on a drastically new concept of forming a
phase-change recording layer by using other elements
than chalcogen. The optical recording medium (1) has a
phase-change recording layer (5) thereof formed such
that a reversible phase change of the phase-change
recording layer (5) between an amorphous phase and a
crystalline phase can be utilized. The phase-change
recording layer (5) contains Sb as a main component and
at least one element selected from the groups
consisting of elements of other groups than group VIb
and rare earth metal elements, as a sub-component,
as e.g. Mn, Ge, In or Ag.
Patent EP-1378938-A2 (EP)
Inventor: YOSHIZAKI ATSUHIRO
IPC: H01L25/07
Filed: 2003-07-03
Abstract: One method of achieving the above subjects is by
connecting a block member 14, which is connected to the
side opposite to that of a semiconductor chip 11
having insulating substrates 12 and 13 connected to the
top and bottom of the semiconductor chip 11, to a block
member 15 across an laminated structure constituted by
the semiconductor chip 11 and the insulating substrates
12 and 13.
Patent EP-1388441-A2 (EP)
Inventor: KERLER JOHANN JUN
IPC: B60G11/27
Filed: 2003-08-08
Abstract: A pressure cylinder or bellows (1) with compressed air connection (7) has a flexible outer wall (19). On application of internal pressure, it expands longitudinally. It surrounds a wheel suspension- or damper rod.
Patent EP-1396904-A2 (EP)
Inventor: KANBA SEIJI
IPC: H01P1/208
Filed: 2001-05-08
Abstract: A dual mode band pass filter comprises a dielectric body (2) having a first main surface and a
second main surface, a metal film (3) partially disposed on the first main surface or at a
certain height in the dielectric body, a ground electrode (4) disposed on the second main
surface or inside the dielectric body in such a manner that the metal film is opposed to the
ground electrode via a portion of the dielectric body, and a pair of input/output coupling
circuits coupled (5a,6a) to different portions of the metal film, wherein, in the region where the
metal film is opposed to the ground electrode via the portion of the dielectric body, some
portions (2a,2b) of the dielectric body have relative permittivities that are different from a relative
permittivity of the remaining portion of the dielectric body so that two resonance modes
generated at the metal film are mutually coupled at a certain resonance frequency.
Patent EP-1426891-A2 (EP)
Inventor: REKINEN TERO
IPC: G06Q30/00
Filed: 2003-11-04
Abstract: The present invention relates
to a method for including the telecommunication
connections needed in the use
of remote monitoring of automatically
operated equipment in contracts between
a company maintaining said equipment and
a client owning said equipment. According
to the method of the invention, the
above-mentioned company takes care of
the administration of the telecommunication
connections, comprising the acquisition
and opening of the aforesaid
telecommunication connections as well as
the invoicing concerning them.
Patent EP-1440854-A2 (EP)
Inventor: EISNER GEORG
IPC: H04W4/90
Filed: 2003-12-04
Abstract: The method involves selecting identities stored in a memory device (5) that is connected via a processing device (2) to a device (1) for establishing a communications connection, whereby the selection of subscriber identities is dependent at least on the location of the device for establishing a communications connection and/or on a voice instruction.  AN Independent claim is also included for the following:  (a) an arrangement for implementing the inventive method; and (b) a method for selection of subscriber identities.
Patent EP-1400502-A2 (EP)
Inventor: PAZZUCCONI GIANNINO
IPC: C07C2/66
Filed: 1999-03-25
Abstract: The present invention concerns a process for
preparing 2,6-dimethylnaphthalene which comprises
subjecting 1,6 and/or 1,5-dimethylnaphthalene, optionally
mixed with other isomers of dimethylnaphthalene, to
isomerization, which comprises treating said compounds at
a temperature ranging from 100 to 400°C, under at least
partially liquid phase conditions, in the presence of an
MTW zeolite.
Patent EP-1353247-A2 (EP)
Inventor: FOCH ETIENNE
IPC: G05B9/03
Filed: 2003-04-08
Abstract: The system for controlling a number of actuators (A11-Anr) comprises at least two processors (L1-Lk) and at least two control modules (C1-Cn) for at least one actuator. Each control module is suitable for controlling at least one actuator by means of at least a first connection (16) and receives information relating to the actuator state by means of a second connection (15). Each control module is connected to at least two processors by means of at least two communications buses (11-13).  An Independent claim is made for a control method in which at least two control modules are used which take decisions relating to control of actuators and which control the actuators as commanded by data received from a number of processors. Each processor receives information from the control modules to which it is connected and determines actuator commands based on the received information.